Advanced search×

Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial.

Andrew M Kaunitz, François Bissonnette, Ilza Monteiro, Eeva Lukkari-Lax, Christoph Muysers, and Jeffrey T Jensen

Obstet Gynecol 116(3):625-32 (2010) PMID 20733445

To compare the efficacy and safety of the levonorgestrel-releasing intrauterine system and oral medroxyprogesterone acetate in the treatment of idiopathic heavy menstrual bleeding.

DOI: 10.1097/AOG.0b013e3181ec622b
Version: za2963e q8za7 q8zb5 q8zc1 q8zd5 q8ze0 q8zfd q8zgb

Similar articles you may find interesting…

  1. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a ...
    Matthias M Schaefers, Christoph C Muysers, ... Claus C Christiansen

    Menopause 16(3):559-65 (2009) PMID 19423999

    Transdermal microdose E2 was similarly effective as raloxifene in preventing bone loss at the lumbar spine. Both treatments were well tolerated, with no clinically significant effect on endometrium or breast density....
  2. Assisted reproductive technologies (ART) in Canada: 2007 results from the Canadian ART Register
    Joanne Gunby, François Bissonnette, ... Lisa Cowan

    Fertil Steril 95(2):0 (2011) PMID 20656287

    To present a report on assisted reproductive technologies (ART) cycles performed in 2007 in Canada and show trends in outcomes over time. This is the seventh annual report from the Canadian ART Register (CARTR). Prospective cohort study. Twenty-six of 26 ART centers in Canada. Couples undergoing ART...
  3. Levonorgestrel intrauterine system: a first-line medical treatment for heavy menstrual bleeding.
    Anita L AL Nelson

    Audio, Transactions of the IRE Professiona... 6(3):347-56 (2010) PMID 20426599